New Novartis chief eyes productivity revolution

vasant-narasimhan

Vasant Narasimhan estimates that using digital technology more efficiently could save up to 25% on the cost of clinical trials.

Read more here.


Leave a Reply

Your email address will not be published. Required fields are marked *


Home / Featured (sidebar) / New Novartis chief eyes productivity revolution